What Are We Really Measuring? (Part 1)
September 16, 2026
When the Biomarker Moves but the Patient Doesn’t Sometimes a drug does exactly what it was designed to do and still fails. That uncomfortable reality...
Read MoreSeptember 16, 2026
When the Biomarker Moves but the Patient Doesn’t Sometimes a drug does exactly what it was designed to do and still fails. That uncomfortable reality...
Read MoreAugust 26, 2026
Part I of this series asked one question: what decision could this board materially change? Without a live uncertainty and real consequence attached to the...
Read MoreAugust 20, 2026
An international consortium of experts outlines a unifying conceptual framework to transform precision diagnostics, therapeutics, and healthy aging strategies TORONTO, CANADA, August 20, 2026 —...
Read MoreAugust 12, 2026
A meeting can run flawlessly and still produce very little decision value. Six advisors just spent four hours dissecting your data. The follow-up report calls...
Read MoreAugust 5, 2026
In the autumn of 2005, investigators in New York and New Jersey began pulling apart a scheme that sounds more like a plot from American...
Read More